Publicacións en colaboración con investigadores/as de University of Paris-Sorbonne (9)

2024

  1. Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non‐Small‐Cell Lung Cancer

    Clinical Lung Cancer, Vol. 25, Núm. 3, pp. 233-243.e8

2022

  1. Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations

    European Journal of Cancer

  2. Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations

    European Journal of Cancer, Vol. 167, pp. 142-148

2021

  1. The prognostic value of respiratory symptoms and performance status in ambulatory cancer patients and unsuspected pulmonary embolism; analysis of an international, prospective, observational cohort study

    Journal of Thrombosis and Haemostasis, Vol. 19, Núm. 11, pp. 2791-2800

2019

  1. Cancer cells in the tumor core exhibit spatially coordinated migration patterns

    Journal of Cell Science, Vol. 132, Núm. 6

  2. Interaction between IGF2-PI3K axis and cancer-associated-fibroblasts promotes anal squamous carcinogenesis

    International Journal of Cancer, Vol. 145, Núm. 7, pp. 1852-1859

2018

  1. Cell migration in tissues: Explant culture and live imaging

    Methods in Molecular Biology (Humana Press Inc.), pp. 163-173

2017

  1. Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX

    European Journal of Cancer, Vol. 82, pp. 16-24

2016

  1. Direct interaction of Ikaros and Foxp1 modulates expression of the G protein-coupled receptor G2A in B-lymphocytes and acute lymphoblastic leukemia

    Oncotarget, Vol. 7, Núm. 40, pp. 65923-65936